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Transmission and lineage displacement drive rapid population
genomic flux in cystic fibrosis airway infections of a
Pseudomonas aeruginosa epidemic strain
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Abstract
Pseudomonas aeruginosa chronic infections of cystic fibrosis (CF) airways are a paradigm for within-host evolution with
abundant evidence for rapid evolutionary adaptation and diversification. Recently emerged transmissible strains have spread
globally, with the Liverpool Epidemic Strain (LES) the most common strain infecting the UK CF population. Previously we
have shown that highly divergent lineages of LES can be found within a single infection, consistent with super-infection
among a cross-sectional cohort of patients. However, despite its clinical importance, little is known about the impact of
transmission on the genetic structure of these infections over time. To characterize this, we longitudinally sampled a meta-
population of 15 genetic lineages within the LES over 13months among seven chronically infected CF patients by genome
sequencing. Comparative genome analyses of P. aeruginosa populations revealed that the presence of coexisting lineages
contributed more to genetic diversity within an infection than diversification in situ. We observed rapid and substantial shifts
in the relative abundance of lineages and replacement of dominant lineages, likely to represent super-infection by repeated
transmissions. Lineage dynamics within patients led to rapid changes in the frequencies of mutations across suites of linked
loci carried by each lineage. Many loci were associated with important infection phenotypes such as antibiotic resistance,
mucoidy and quorum sensing, and were repeatedly mutated in different lineages. These findings suggest that transmission
leads to rapid shifts in the genetic structure of CF infections, including in clinically important phenotypes such as
antimicrobial resistance, and is likely to impede accurate diagnosis and treatment.
DATA SUMMARY
1. DNA sequence data are available from the European
Nucleotide Archive under accessions PRJEB6642 and
PRJEB20763.
INTRODUCTION
Pseudomonas aeruginosa has typically been considered an
opportunistic pathogen that lives in the environment but
can also infect susceptible individuals [1]. In particular,
patients with cystic fibrosis (CF) are susceptible to chronic
bacterial infections of the airway, and such infections, once
established, are extremely difficult to clear, can last many
years and, despite antibiotic and other interventions, are
associated with continued decline of lung function leading
to death or lung transplant [2]. Chronic infections of CF
airways by P. aeruginosa strains provide a powerful model
to understand the evolutionary processes associated with
the adaptation of bacterial pathogens to survive within the
human host [3, 4]. DNA sequencing of longitudinal samples
of environmentally acquired infections has revealed a num-
ber of genetic changes associated with adaptation, including
switch to a mucoid phenotype, loss of quorum sensing and
motility, and development of auxotrophy, hypermutability
and antibiotic resistance [5, 6]. It is now apparent,
however, that, alongside environmentally acquired strains,
patient-to-patient transmission is also common, predomi-
nantly through a subset of specialized pathogen strains –
termed transmissible or epidemic strains – that appear to
have adapted to both survive within the human airway and
retain the ability to transmit between patients [7–9].
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Transmissibility (i.e. the ability to transmit between
patients) appears to have evolved repeatedly and indepen-
dently, since genetically distinct transmissible strains have
been reported from studies in Australia, Belgium, Canada,
Denmark and the UK [9–11].
The Liverpool Epidemic Strain (LES) is the most common
transmissible strain in the UK, has also been found in North
America, and is associated with both higher virulence in
laboratory models and poorer patient outcomes than
environmentally acquired strains [12–15]. Little is known
about how transmission affects the population genetic struc-
ture of CF infections. We have previously demonstrated
that the population of LES bacteria infecting a single patient
is composed of a diversity of genetically and phenotypically
distinct clones, which differ in traits believed to be associ-
ated with adaptation to human airways [6, 14, 16–18].
Whole genome sequencing of multiple clones recovered
from a single sample shows that diversification, due to de
novo mutation, is a prominent feature of genome evolution
in chronic infections for the LES [18]. Using a cross-
sectional sample of multiple patients attending the same
clinic, we have also demonstrated coexistence of multiple,
divergent lineages of the LES that are inconsistent with a
single source of infection. Thus, patients can be infected
with multiple lineages of the LES, either as part of the origi-
nal inoculum or as a result of distinct transmission events
(super-infection). Unlike in environmentally acquired infec-
tions, for transmissible strains genetic diversity within a
chronic infection arises both by in situ diversification of an
infecting clone into a clonal lineage and by coexistence
within an infection of multiple clonal lineages acquired by
recurrent transmission [18]. There is substantial phenotypic
variation between samples of the LES taken from patients at
successive time points [16, 17], which suggests that recur-
rent transmissions may be driving rapid population geno-
mic flux in LES infections of the CF airway.
From a clinical perspective, diversity within an infection
makes P. aeruginosa, and other pathogens, difficult to treat
because an infection may maintain a reservoir of genetic
diversity able to evolve rapidly in response to either host
immune responses or clinical interventions, including anti-
biotics [3, 6, 19]. Changes in the genetic structure of the
infection through time may also have significant implica-
tions for the health of a patient, should the frequency of
traits associated with pathology change through time.
Unlike in situ diversification by de novo mutation [4],
acquisition of new diversity via transmission is likely to rep-
resent a larger-scale alteration to population genetic struc-
ture, affecting many loci simultaneously and much more
rapidly than would occur via mutation-selection [20], yet
little is known about the temporal dynamics of genetic
diversity in CF infections caused by transmissible strains.
Here we build on our previous work, particularly our geno-
mic analysis of single sputum samples from a group of LES-
infected patients [18], to use whole genome sequencing to
analyse the genetic structure of chronic P. aeruginosa LES
infections through a series of longitudinal samples from
each of seven patients from the same CF clinic.
METHODS
Patients and samples
Longitudinal samples were collected from seven adult CF
patients, each chronically infected with the P. aeruginosa
LES, as described previously [16]. Briefly, a sputum sample
was collected from each patient at a routine visit to the
Regional Adult Cystic Fibrosis Unit in Liverpool, UK, dur-
ing January 2009. Sputum was treated with an equal volume
of Sputasol (Oxoid), incubated at room temperature with
shaking at 200 r.p.m. for 15min, and then cultured on
Pseudomonas selective agar under aerobic conditions with
CN supplement (Oxoid) and 40 LES colonies were selected
to maximize colony morphology diversity and identified as
described previously [16–18]. Details concerning age, sex
and clinical status of patients are summarized in Tables S1
and S2 (available in the online version of this article) and in
a previous publication [17]. CF01, CF03, CF05 and CF07
are known to have been LES-positive since at least 1995;
CF04 and CF09 since 2004; and CF08 since at least 2008.
DNA sequencing
DNA was extracted from isolates grown in Luria Broth
overnight at 37

C using the Wizard Genomic DNA Purifi-
cation Kit (Promega). The purity of the extracted bacterial
DNA was assessed using the Nanodrop ND-1000 spectro-
photometer and the quantity of bacterial DNA was mea-
sured using the Qubit 2.0 Fluorometer following the
manufacturer’s protocol (Life Technologies). For each sam-
ple, two isolates were individually sequenced and equimolar
pools of 40 isolates were sequenced (Table S2). An Illumina
HiSeq 2000 sequencer was used to generate 100 bp paired
reads from the ends of 500 bp fragments. Sequenced read
IMPACT STATEMENT
Cystic fibrosis (CF) patients are susceptible to lifelong
infections of the airways caused by Pseudomonas aerugi-
nosa. In the UK there is a widespread CF transmissible
strain [the Liverpool Epidemic Strain (LES)], which is
associated with poorer patient health. Genetic diversity
within the lung makes CF infections harder to treat but
how transmission between patients affects diversity is
unknown. Genome sequencing of P. aeruginosa popula-
tions from a cohort of LES-infected CF patients over one
year showed that most genetic diversity within infections
was due to the acquisition of genetically diverged P. aeru-
ginosa lineages by transmission. The frequency and iden-
tity of these lineages within infections changed rapidly,
causing wholesale shifts in a suite of genes linked to
pathology. Transmission increases genetic diversity in
CF infections and boosts the rate and magnitude of evo-
lutionary change, posing challenges for treatment.
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data in fastq files were trimmed for the presence of Illumina
adapter sequences using Cutadapt version 1.2.1 [21]. The
option -O 3 was used, so the 3¢ end of any reads which
match the adapter sequence for 3 bp or more is trimmed.
The reads are further trimmed using Sickle version 1.2 [22]
with a minimum window quality score of 20. Reads shorter
than 10 bp after trimming were removed.
Variant calling
The Genome Analysis Toolkit (GATK) Indel Realigner
module was used to realign raw reads around indels [23].
Single nucleotide polymorphism, insertion and deletion dis-
covery was performed with GATK’s Unified Genotyper
module [23] with sample ploidy n=1 or n=40 for single and
pooled isolates, respectively. GATK was further used to fil-
ter sequence variants using standard conservative filtering
parameters to provide high-quality variant calls. False posi-
tive SNP variants at structural mismatches between sample
genome sequence and the reference genome sequence (e.g.
an absent prophage sequence) were mitigated by omitting
variants at positions where aligned read coverage depth was
less than 25% of the genome-wide median. Contiguous
regions greater than 10 bp in the reference genome along
which no sequenced reads were aligned were considered
missing in the genome from which the reads were derived.
SNPs, insertions and deletions reported by GATK within
annotated protein coding regions of the reference genome
(LESB58) were classified on the basis of potential pheno-
typic effects using snpEff v3.1 [24].
Statistical analysis
Genome phylogenies were first reconstructed for single
clones using the BioNJ algorithm on raw counts of nucleo-
tide differences between pairs of sequences as implemented
in the APE version 3.1–2 for the R statistical computing
environment version 3.1.0. In order to validate key biparti-
tions of the BioNJ-derived phylogeny, phylogenies were also
reconstructed by maximum likelihood using the IQ-Tree
package [25], ModelFinder for substitution model selection
[26] and the UFBoot2 non-parametric bootstrap approxi-
mation [27] with 1000 replicates to test clade support. The
command used was ‘iqtree-omp -m MFP -st DNA -nt
AUTO -bb 1000 –s multiple_sequence_alignment.fna’.
Rooting was inferred using LESB58 as an outgroup (shown
previously to be suitable; [18]). The k3Pu substitution
model [28] modified for unequal base frequencies and with
no among-site rate correction was selected based on the
Bayesian information criterion. Lineages were defined as
coherent sets of isolates with high genetic similarity to each
other but divergent from each other based on substitutions
on branches within the phylogeny (Supplemental materials
and Fig. S1). For each sample, divergent, coexisting lineages
were defined as any pair of clades whose respective most
recent common ancestors (MRCAs) are further from each
other than their shared MRCA is from that of all patient iso-
lates, i.e. of this epidemic. All lineage edges had 100% boot-
strap support by both phylogenetic methods. For pooled
samples, SNPs fixed within lineages were assigned on the
basis of allele frequencies within the pool and from one or
more clone sequences from a sample [18] (Supplemental
materials and Fig. S2).
Nucleotide variation within samples – the average number
of nucleotide differences between a randomly drawn pair of
isolates – due to diversification in situ versus fixed differen-
ces between lineages was estimated for patient CF3, where
five samples containing the same pair of lineages was avail-
able. Monte Carlo simulation was used to generate a null
distribution for technical variation in lineage proportions
due to sampling, which could be contrasted against
observed variation between samples.
Quantitative PCR
Based on the sequencing results, lineage-specific primers
were successfully designed to span mutations identified in
lineages D and I (Table S3). LESB58 DNA was used as a
negative control. To validate the method, 40 individual iso-
lates from sample CF7S1 were subjected to PCR amplifica-
tion primers for lineage D and 4/40 isolates showed positive
amplification, which supports the lineage prediction from
the pooled sequencing data.
DNA extracted from sputum samples was used in quantita-
tive PCR assays. Each sputum sample was treated with an
equal volume of Sputasol (Oxoid) and incubated at 37

C
for 30min, with shaking at 200 r.p.m. DNA was prepared
from each treated sputum sample (400 µl) using the ‘Qia-
symphony Virus/Pathogen DNA extraction kit’ (Qiagen)
and the automated QIAsymphony machine (Qiagen; patho-
gen complex 200 protocol). P. aeruginosa total density was
quantified using primers specific for P. aeruginosa (gyrPA-
F1/gyrPA-R1) [29] and specific lineages. All primer sequen-
ces and targets are listed in Table S3. Quantitative real-time
PCR (qPCR) was performed using the Rotor-Gene Q cycler
(Qiagen) and 0.1ml strip-tubes (Qiagen). Each 25 µl reac-
tion consisted of 1 Rotor Gene SYBR Green PCR Master
Mix (Qiagen), specific forward and reverse primers
(Table S3), and 2 µl cDNA and molecular-grade water
added to a final volume of 25 µl. Thermal cycling was per-
formed as follows: activation of DNA polymerase at 95

C
for 5min, followed by 40 cycles of 95

C for 10 s, 60

C for
15 s and 72

C for 20 s. Fluorescence data were collected at
the end of every 72

C step. PCR products were subse-
quently analysed by melting curve analysis ranging from 72
to 95

C. Each qPCR was performed in triplicate and a stan-
dard curve of known copy number was performed in each
run. No-template controls were included in each qPCR and
contained molecular-grade water instead of template DNA.
When necessary, qPCR products were analysed by agarose
gel electrophoresis. Obtained data were analysed using the
Rotor-Gene Q series software (Qiagen).
RESULTS
Genetic structure of P. aeruginosa LES lineages
We examined the genetic diversity of chronic P. aerugi-
nosa LES infections among a set of CF patients from a
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single clinic, sampled longitudinally over the course of
approximately one year. These patients were in contact
with each other but separated from other CF patients.
Genome sequencing was performed on a combination of
single isolates and pools of isolates from each sample.
The phylogenetic relationship among single isolates is
shown in Fig. 1 and, consistent with a previous report
[18], demonstrates the existence of divergent lineages
within the LES populations infecting these patients. The
majority of samples contained more than one lineage and
some lineages (B, K and I) were shared between patients,
which is inconsistent with diversity arising from a single
infection event by a single clonal genotype. Given the
high potential for transmission of the LES amongst
patient cohorts, it is likely that patients acquire novel LES
lineages by super-infection [13, 30]. In support of this,
patients CF07 and CF09 share a lineage (J) that exhibits a
hypermutator phenotype [31] that rapidly accumulates
genetic substitutions and so allows a high resolution of
their genetic relationship. Here samples clearly cluster by
Fig. 1. Genetic structure of Pseudomonas aeruginosa lineages. The figure shows a rooted neighbour-joining (BioNJ) phylogenetic
reconstruction, where labels by each tip give patient, sample and isolate name (i indicates a sequenced isolate and UL an unsampled
isolate within a sample inferred from pooled sequencing data; S indicates a sample taken from a patient while clinically stable and A
from a patient during an acute exacerbation). Divergent coexisting lineages are defined as exhibiting greater divergence from each
other relative to the divergence between their most recent common ancestor (MRCA) and that of the MRCA of all patient isolates.
Edges defining lineages are shown in red and have 100% bootstrap support in all cases. See Fig. S1 for an illustrative example. In
each case, lineages are observed to be separated from any other lineage by at least 30 substitutions and in some cases several
hundred. Lineage J has undergone hypermutation and its branch length is abbreviated for clarity on the main plot but shown in the
insert panel.
Williams et al., Microbial Genomics 2018;4
4
Downloaded from www.microbiologyresearch.org by
IP:  139.222.162.213
On: Wed, 04 Apr 2018 13:13:33
lineage rather than by patient, consistent with transmis-
sion of lineages between patients (Fig. 1).
We then sequenced pools of 40 isolates and, by combining
with single isolate data as described previously [18], were
able to infer a total of 15 lineages among 21 samples from
seven patients. Coexisting lineages were detected in 18 of 21
samples. Coexistence of highly diverged lineages within
populations is therefore a common feature of infection with
this transmissible strain and contributes more to genetic
diversity within infections than in situ mutation. This is
demonstrated in patient CF03, where lineages G and O
coexisted in the five samples taken from this patient and
contributed more to the genetic diversity (average number
of nucleotide differences between a pair of randomly drawn
isolates) present within infections than diversification in
situ (an average of 49.8 fixed lineage differences versus 19.8
mutations via diversification in situ; paired t-test t=10.8,
d.f.=4, P<0.001, Table 1).
Lineage dynamics within P. aeruginosa LES
infections
Longitudinal sampling revealed rapid fluctuations in the rel-
ative frequencies of coexisting lineages within a patient
(Fig. 2). For example, samples taken from patient CF03
showed the frequency of lineage O varying between 22 and
58% over the course of a month, which is significantly
greater than expected by sampling variation alone (P<0.05
by Monte Carlo simulation). More striking is the loss or
replacement of lineages through time. In patient CF07, line-
ages K and D were observed in the initial January 2009 sam-
ple but were not detected in later samples. Thereafter,
lineages I and J dominated. Nevertheless, sampling 40 iso-
lates per sample has a limited resolution to detect persis-
tence of lineages at a low abundance. From a binomial
distribution, sampling 40 isolates will detect a 0.04 SNP fre-
quency with 80% power and a 0.07 SNP frequency with
95% power. To increase resolution further, and to check for
errors due to sample mislabelling, we performed qPCR
assays to detect lineages I and D from these samples, plus
two intermediate, unsequenced sputum samples. Lineage D
was confirmed in all samples that were tested by qPCR (Fig.
S3), which excludes sample mislabelling as a source of error.
Lineage I was present in all samples but was detected
only at a low level in January 2009 (compared to total
P. aeruginosa) whereas levels were substantially higher
during the following month (Fig. S4). In contrast, loss of
lineage I was observed in patient CF09 (Fig. S4). Here, line-
age I was at high frequency in January 2009 but could not
be detected by qPCR in sputum samples subsequently and,
from sequence data in December 2009 and January 2010,
appeared to have been replaced by lineage K. From pooled
sequence data (Fig. 2), similar turnover of lineages was
observed in patient CF01, where lineage B was lost or fell
below detectable levels, and in patient CF04 where lineages
B and C fell below detectable levels for lineages E and F to
then dominate. Nevertheless, lineage turnover was not ubiq-
uitous, because in three of the seven patients, CF03, CF05
and CF08, the same lineages were detected throughout the
study.
Rapid genetic changes at pathoadaptive loci
Many loci previously proposed to underlie clinically import-
ant phenotypic traits exhibited two clear patterns. First, they
were repeatedly and independently mutated in different lin-
eages (Fig. 3). Thus, although the same genes were subject
to mutations in different lineages, different nucleotide sites
were mutated in each case, indicating that mutations have
not arisen in one lineage and spread via recombination. Pre-
viously we have shown that rates of recombination among
these samples is low [32]. Such parallel mutations highlight
targets of natural selection and support the role of these loci
in adaptation to the CF lung. Second, the frequency of these
mutations often changed rapidly through time, concomitant
with the turnover in lineages that we observed at the popu-
lation level. The quorum sensing regulator lasR, which regu-
lates expression of many of the P. aeruginosa virulence
genes, was a repeated target of selection, corroborating pre-
vious observations of loss of LasR in chronic CF infections
[33, 34]. Examples of the frequency dynamics in lasR, and
other genes, are shown in Fig. 4. Patient 4 exhibited a rise in
lasR mutation frequency from 28 to 100% within 35 days,
which was associated with the replacement of lineages
detected in this patient. In patient 5, no replacement of line-
ages was observed but changes in the relative abundance of
the two coexisting lineages was observed, concomitant with
a drop in frequency of lasR mutations from 100 to 37%
over 8months. By contrast, in patient 8, lasR mutation fre-
quency was relatively constant in three successive samples
over 3months. Similar patterns were observed for other
Table 1. Analysis of genetic variation due to fixed lineage differences and in situ mutation in samples from patient CF03
Sample Date Total diversity* Due to lineage component Due to in situ mutation Estimated abundance of lineage G†
CF03-S1 06/01/2009 68.5 51.8 (76%) 16.7 (24%) 63%
CF03-S2 20/01/2009 76.9 54.0 (70%) 22.9 (30%) 42%
CF03-A1 25/01/2009 60.2 40.4 (67%) 19.8 (33%) 77%
CF03-A2 27/01/2009 69.1 48.2 (70%) 20.9 (30%) 68%
CF03-A3 03/02/2009 73.1 54.4 (74%) 18.7 (26%) 59%
*Nucleotide diversity; the average number of nucleotide differences between two randomly picked genomes.
†CF03 infections were composed of two lineages, G and O.
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pathoadaptive loci: mucA and algG, associated with colony
morphology variation, and linked with resistance to envi-
ronmental stressors, including host defence and antibiotics
[35]; pvdS, encoding a sigma factor required for pyoverdine
synthesis to scavenge for iron during invasion, but which
tends to be lost as iron becomes more available later in
Fig. 2. Lineage dynamics within Pseudomonas aeruginosa infections. The abundance inferred for each of 15 lineages from pooled
sequencing of 40 isolates per sample from longitudinal samples of seven patients is shown. Asterisks indicate periods between sam-
ples where lineages are either lost or fall in frequency below the limit of detection from sequencing 40 isolates per sample. Individual
lineages are colour-coded as indicated in the insert panel, and their frequencies within sets of 40 isolates per sputum sample indi-
cated with stacked frequency box plots at different sampling time points for each patient (CF01, CF03, CF04, CF05, CF07, CF08, CF09).
Fig. 3. Parallel mutations within loci among Pseudomonas aeruginosa lineages. Loci with fixed mutations in two or more lineages are
shown. The nucleotide identity of mutations is different in different lineages, indicating independent origins of mutations. All mutations
shown result in coding changes. Loci previously implicated in pathoadaptation are highlighted. The 6.6 Mbp genomes of lineages A–O
are arranged concentrically, with lineage A innermost, and the origin of replication at the top.
Williams et al., Microbial Genomics 2018;4
6
Downloaded from www.microbiologyresearch.org by
IP:  139.222.162.213
On: Wed, 04 Apr 2018 13:13:33
infection [36] or other iron acquisition systems are favoured
[37]; and mexA and mexB, which encode two components
of an efflux pump (MexA-MexB-OprM), associated with
both antibiotic resistance and virulence [38, 39]. Loss of
function mutations in mexA and mexB, as seen here and
reported in other P. aeruginosa chronic lung infections [40],
would probably lead to reduced efflux of both antibiotics
and virulence factors.
DISCUSSION
Our data demonstrate that the genetic composition of a
chronic infection by a transmissible strain changes rapidly
through time, driven in large part by the turnover of geneti-
cally divergent lineages. While some lineages may be main-
tained within the lungs at low frequency, there is also clearly
the potential for some lineages to be lost. The fact that coex-
istence of divergent lineages within a patient is widespread,
despite loss of lineages, provides further evidence that new
lineages can be acquired through the course of infection [18,
30]. The patients here were all chronically infected by the
LES, attended the same clinic and were treated as a cohort
[16, 17]. The LES is known to be highly transmissible (in
comparison with environmental strains [9]) and these data
suggest that it is readily able to super-infect susceptible indi-
viduals [30]. It is also notable that no other P. aeruginosa
strain has been observed in these patients, which may sug-
gest that the LES is able to outcompete other strains.
The LES is common in the UK and regions of Canada, but
is only one of a number of transmissible strains that have
been identified [41]. Only recently have studies started to
sample multiple clones from P. aeruginosa infections at suf-
ficient depth to investigate heterogeneity within infections,
so it remains unclear how widespread the coexistence of
multiple lineages are or their dynamics. Nevertheless, the
data available indicate that other transmissible strains can
harbour high levels of phenotypic heterogeneity [19]. Corre-
sponding genomic data are available only for a small num-
ber of such strains, notably the DK02 lineage [42] but, here,
stable coexistence of three independent sublineages was
found in one patient [31]. Two small studies of multiple iso-
lates from the same sputum sample suggested that coexis-
tence of distinct lineages is not restricted to transmissible
strains [43, 44]. Similarly, coexistence of distinct lineages
has been reported in non-CF bronchiectasis infections [40].
It has been suggested – although not in the context of trans-
missible strains – that the coexistence of multiple subli-
neages is a consequence of the spatial heterogeneity in the
lungs, whereby populations establish in physically separate
populations and diverge in response to different selective
pressures [45]. Evidence for the concept of regional isolation
driving diversification was presented in a study of P. aerugi-
nosa populations from different areas of explanted lungs
from CF patients [46]. However, it has also been shown that
even in a simple environment, stable coexistence can be
maintained with multiple beneficial variants competing for
dominance [47].
Competition between lineages may be an important feature
of chronic Pseudomonas infections, which may drive much
of the turnover of LES lineages that we observe within
patients [6, 7]. It is notable that similar dynamics have
recently been reported in pneumococcal infections, where
negative frequency-dependent selection was shown to main-
tain genetic diversity [48]. With respect to patient health,
many of the mechanisms used by bacteria in intra- or inter-
specific competition are also involved in pathogenicity [49],
suggesting traits associated with virulence may be main-
tained if they allow clones to defend space or resources [7,
49]. In support of this, many of the loci targeted by natural
selection (evidenced by parallel mutation in multiple line-
ages) have previously been implicated in both clinical
pathology and bacterial competition in a range of P. aerugi-
nosa strains [41, 50]. In addition, selection for increased
transmission may itself select for competitive ability,
because following transmission LES lineages must compete
with the resident lineage(s) in order to super-infect. It is
known that, whereas adaptation to the lung environment
has been proposed to decrease bacterial virulence in
Fig. 4. Rapid genetic changes at pathoadaptive loci. Examples of changes in abundance of mutations (shaded area) at six loci (mexA,
mexB, algG, mucA, pvdS and lasR) for patients CF04, CF05 and CF08 are shown. Major changes in frequency, corresponding to changes
in lineage frequency, are observed over a short time period for patient CF04, and over a longer period for patient CF05, whereas
patient CF08 shows stable frequencies between the three time points.
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environmentally acquired strains [9], the LES and other
transmissible strains are notable for maintenance of high
virulence, resulting in poor patient prognosis in clinical
studies [3, 14, 15]. This may therefore reflect a history of
repeated transmissions selecting for the retention of viru-
lence related traits that are important during colonisation.
Our data show that, where lineages co-occur within an
infection, the majority of genetic variation is attributable to
differences between lineages, rather than in situ diversifica-
tion following infection. Super-infection by a lineage can
therefore provide a substantial source of new genetic diver-
sity, and introduce a suite of mutations at clinically relevant
loci such as virulence traits or antibiotic resistance. Previ-
ously, we have shown that recombination within infections
is rare and so mutations carried by a lineage remain distinct
from other such lineages [32]. This linkage between loci
means that a change in frequency of a mutation may be
driven by selection elsewhere in the genome [20]. This could
include mutations relevant to virulence increasing in fre-
quency by hitchhiking with a linked mutation conferring
antibiotic resistance. This extensive diversity present within
chronic P. aeruginosa infections – of the LES and possibly
other epidemic strains – coupled with the often rapid turn-
over in lineages, suggests that such genetic dynamics may
make the clinical outcome of interventions unpredictable.
Longitudinal population genomic sequencing of a transmis-
sible P. aeruginosa strain from multiple patients has
revealed the coexistence of highly diverged lineages within
individual patients and rapid turnover of lineages over time.
The acquisition of new lineages by transmission represents
a major influx of genetic diversity to a chronic infection and
greater than that observed for diversification in situ. The
population genomic structure of infections showed rapid
shifts as lineages competed with or displaced each other.
Because each lineage consists of a set of linked loci affecting
a suite of phenotypic traits including key pathoadaptive loci,
transmission and lineage turnover dynamics lead to much
faster change than might be expected by mutation and selec-
tion during adaptation of an environmental strain to the CF
airway. Our results emphasize the importance of infection
control among cohorts of CF patients to prevent the acqui-
sition of novel P. aeruginosa lineages and the subsequent
competition between lineages, which may exacerbate the
pathology associated with transmissible strains [8, 14].
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